ES2036545T3 - Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos. - Google Patents

Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.

Info

Publication number
ES2036545T3
ES2036545T3 ES198787108481T ES87108481T ES2036545T3 ES 2036545 T3 ES2036545 T3 ES 2036545T3 ES 198787108481 T ES198787108481 T ES 198787108481T ES 87108481 T ES87108481 T ES 87108481T ES 2036545 T3 ES2036545 T3 ES 2036545T3
Authority
ES
Spain
Prior art keywords
tetrazole
carboxamide
derivatives
ring
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787108481T
Other languages
English (en)
Inventor
Wiaczeslaw Antin Cetenko
David Thomas Connor
Michael David Mullican
Roderick Joseph Sorenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2036545T3 publication Critical patent/ES2036545T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE N-1H-TETRAZOL-5-YL-(5-ANILLO)-CARBOXAMIDA QUE TIENEN LA FORMULA DE N-1H-TETRAZOL- 5-YL-3-TIOFENO-CARBOXAMIDAS, N-1H-TETRAZOL-5-YL-2- FURANCARBOXAMIDAS O ANALOGOS DE CADA CARBOXAMIDA. LOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE CONDICIONES O ENFERMEDADES ALERGICAS O INFECCIOSAS. LA INVENCION INCLUYE TAMBIEN COMPOSICIONES FARMACEUTICAS Y SU USO TAMBIEN PROCESOS DE PREPARACION PARA LOS COMPUESTOS.
ES198787108481T 1986-06-13 1987-06-12 Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos. Expired - Lifetime ES2036545T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87430986A 1986-06-13 1986-06-13
US07/027,453 US4748183A (en) 1986-06-13 1987-03-18 N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof

Publications (1)

Publication Number Publication Date
ES2036545T3 true ES2036545T3 (es) 1993-06-01

Family

ID=26702504

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787108481T Expired - Lifetime ES2036545T3 (es) 1986-06-13 1987-06-12 Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.

Country Status (14)

Country Link
US (1) US4748183A (es)
EP (1) EP0249236B1 (es)
KR (1) KR880011149A (es)
AU (1) AU591409B2 (es)
CA (1) CA1320208C (es)
DE (1) DE3769518D1 (es)
DK (1) DK296687A (es)
ES (1) ES2036545T3 (es)
FI (1) FI872598A7 (es)
GR (1) GR3001852T3 (es)
NO (1) NO872456L (es)
NZ (1) NZ220541A (es)
PH (1) PH23929A (es)
PT (1) PT85072B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64995B1 (en) * 1987-07-14 1995-09-20 Warner Lambert Co Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome
IT1228893B (it) * 1989-02-24 1991-07-09 Valeas Spa Derivati tetrazol ammidici di acidi alchenil eterociclici e loroimpiego come sostanze antiallergiche
DD298912A5 (de) * 1989-11-17 1992-03-19 �������@������������@��k�� Verfahren zur herstellung von 3-aminopyrrolen
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
EP0526732A3 (en) * 1991-07-11 1993-05-05 E.I. Du Pont De Nemours And Company Processes for the preparation of heterocyclic thiocarbamates
CN1308305C (zh) * 2005-04-21 2007-04-04 浙江工业大学 合成酰亚胺基取代的桥环化合物的方法
AU2006285306B2 (en) * 2005-07-25 2012-07-19 Avianax, Llc. Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750393A (en) * 1954-12-01 1956-06-12 Sterling Drug Inc Iodinated 5-henzamidotetrazoles and preparation thereof
GB1343827A (en) * 1971-06-15 1974-01-16 Science Union & Cie Acylaminotetrazoles and process for preparing them
DE3002545A1 (de) * 1980-01-25 1981-07-30 Basf Ag, 6700 Ludwigshafen 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4503236A (en) * 1982-04-19 1985-03-05 Warner-Lambert Company Antiallergic 4Hfuro[3,2-b]indoles
IE58555B1 (en) * 1984-12-10 1993-10-06 Warner Almbert Company Novel benzothiophenes and benzofurans having antiallergy activity

Also Published As

Publication number Publication date
GR3001852T3 (en) 1992-11-23
NZ220541A (en) 1990-08-28
US4748183A (en) 1988-05-31
FI872598L (fi) 1987-12-14
DK296687A (da) 1987-12-14
EP0249236B1 (en) 1991-04-24
PT85072A (en) 1987-07-01
PH23929A (en) 1990-01-23
NO872456L (no) 1987-12-14
DK296687D0 (da) 1987-06-10
FI872598A0 (fi) 1987-06-10
FI872598A7 (fi) 1987-12-14
PT85072B (pt) 1990-03-08
NO872456D0 (no) 1987-06-12
EP0249236A1 (en) 1987-12-16
DE3769518D1 (de) 1991-05-29
AU7387787A (en) 1987-12-17
AU591409B2 (en) 1989-11-30
CA1320208C (en) 1993-07-13
KR880011149A (ko) 1988-10-26

Similar Documents

Publication Publication Date Title
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES2124707T3 (es) Compuestos heterociclicos y su preparacion y utilizacion.
ES2193901T1 (es) Derivados de prostaglandina para el tratamiento de glaucoma o hipertension ocular.
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
ES2061452T3 (es) Nuevas hetrazepinas y procedimiento para su preparacion.
ES2147238T3 (es) Nuevos analogos estructurales de la vitamina d.
ES2084944T3 (es) Amidas terapeuticas.
ES2110997T3 (es) 1,2,5,6-tetrahidro-1-metilpiridinas, su preparacion y uso.
MX9303145A (es) 7-(2-aminoetil)benzotiazolonas.
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
ES2141787T3 (es) Derivados de la 1,2,3,4-tetrahidro-9-acridinamina.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2036545T3 (es) Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.
ES2032384T3 (es) Procedimiento para preparar derivados de carboxamidas.
ES2046193T3 (es) Un procedimiento para la preparacion de un compuesto de imidazolidinona.
ES2039408T3 (es) Un procedimiento para preparar un compuesto de tienotriazolodiazepina.
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados
MX9405110A (es) Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores.
ES2038176T3 (es) Un procedimiento para la preparacion de derivados del naftaleno.
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.
ES2012736A6 (es) Procedimiento para la preparacion de derivados triciclicos de 3-oxopropanonitrilo.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.
NO903430L (no) Fremgangsmaate for fremstilling av aminoketonderivater.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 249236

Country of ref document: ES